ArticleDigestive diseases and sciences2020

LRRK2 Is Associated with Recurrence-Free Survival in Intrahepatic Cholangiocarcinoma and Downregulation of LRRK2 Suppresses Tumor Progress In Vitro.

Shen Gu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.